¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Visual pathway glioma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® glioma ÇÑ±Û ½Å°æ¾Æ±³Á¾
¼³¸í   
  ³ú¿Í Ã´¼öÀÇ ³»ºÎ¿¡ ÀÖÀ¸¸é¼­ ½Å°æÁ¶Á÷ÀÇ °áÇÕ-ÁöÁö-¿µ¾ç µîÀÇ ÀÛ¿ëÀ» Çϴ ½Å°æ¾Æ±³¼¼Æ÷¿¡¼­ ±â¿øÇϴ Á¾¾ç. ½Å°æ¾Æ±³Á¾Àº Æ¯È÷ ³ú¿¡ ÈçÈ÷ ¹ß»ýÇϸç, Àüü ³úÁ¾¾çÀÇ ¾à 40%¸¦ Â÷ÁöÇÑ´Ù. Ä§À±¼º ¼ºÀåÀ» Çϰí Á¤»óÁ¶Á÷°úÀÇ °æ°è°¡ ºÐ¸íÇÏÁö ¾Ê¾Æ ¿Ü°úÀûÀ¸·Î À̰ÍÀ» ¿ÏÀüÈ÷ Á¦°ÅÇϱ⠾î·Á¿ì¸ç ¿ÏÄ¡°¡ °ï¶õÇÏ´Ù. ÀÌ º´Àº ´Ù½Ã ¸î °³ÀÇ ¹«¸®·Î ³ª´©¾îÁö´Âµ¥, º°¾Æ±³¼¼Æ÷Á¾, Èñµ¹±â¾Æ±³¼¼Æ÷Á¾, ³ú½Ç¸·¼¼Æ÷Á¾À̸ç, ±× Áß¿¡¼­ °¡Àå ¸¹Àº °ÍÀº º°¾Æ±³¼¼Æ÷Á¾ÀÌ´Ù. À̰ÍÀº ¶Ç ´Ù½Ã ±× ¾Ç¼ºµµ¿¡ µû¶ó¼­ 3±ºÀ¸·Î ³ª´©¾îÁø´Ù. ¾ç¼ºÀº 10³â ÀÌ»ó »ýÁ¸ÇÒ ¼ö ÀÖÀ¸³ª, ¾Ç¼ºÀº 1³â ÀÌ»ó »ýÁ¸ÇÏ±â ¾î·Æ´Ù.
¿µ¹® visual acuity ÇÑ±Û ½Ã·Â
¼³¸í   
  ´«À» °¡Áö°í Á¤È®È÷ º¸¾Æ ½Äº°ÇÒ ¼ö Àִ ´É·ÂÀÌ´Ù. ½Ã·ÂÇ¥¸¦ ÀÌ¿ëÇÏ¿© ÃøÁ¤ÇÑ´Ù. 5m¹Û¿¡¼­ ½Ã·ÂÇ¥¸¦ º¸¾Æ 2/3ÀÌ»ó ÀÐÀ» ¼ö Àִ ÃÖ´ë½Ã·ÂÀ» ½Ã·ÂÀ¸·Î Á¤ÇÑ´Ù. Á¤È®ÇÑ ½Ã·Â°Ë»ç´Â »êµ¿Á¦¸¦ Åõ¿©ÇÏ¿© ´«ÀÇ Á¶ÀýÀ» ¸·°í, °Ë¾È°æÀ¸·Î °Ë»çÇØ¾ß ÇÑ´Ù.
¿µ¹® visual field test ÇÑ±Û ½Ã¾ß°Ë»ç
¼³¸í   
  ´«À» ÇѰ÷¿¡ °íÁ¤½ÃŲ Ã¤, °üÂûÇÒ ¼ö Àִ ÁÖº¯°ø°£À» ½Ã¾ß¶ó ÇÑ´Ù. ½Ã¾ß¸¦ °Ë»çÇϴ °¡Àå °£´ÜÇÑ ¹æ¹ýÀº ´ë¸é°Ë»ç(confronting test)ÀÌ´Ù. À̰ÍÀº Çǰ˻çÀÚÀÇ ´«À» °Ë»çÀÚÀÇ ´«¿¡ ¸ÂÃ߾¸µµ·Ï ÇÏ¿© ´«À» °íÁ¤½ÃŲä, °Ë»çÀÚ°¡ ¼Õ°¡¶ô³¡À» À§ÂÊ, ¾Æ·¡ÂÊ, ¿ÞÂÊ, ¿À¸¥ÂÊ, ±×¸®°í ºñ½ºµëÈ÷ °æ»çÁø °÷ µîÀ¸·Î ¿Å°Üº¸¾Æ Çǰ˻çÀÚ°¡ °üÂûÇÒ ¼ö ÀÖ´ÂÁö ¿©ºÎ¸¦ Á¤Çϴ °Ë»ç¹ýÀÌ´Ù. À̺¸´Ù Á¤È®ÇÑ °Ë»ç¹ýÀº ÀÚµ¿½Ä ÄÄÇ»Åͽþ߰˻ç¹ýÀÌ ÀÖ´Ù. ´ë°³, ´«ÀÚüÀÇ ÀÌ»óÀÌ À־ ½Ã¾ß°Ë»ç¿¡¼­ ÀÌ»óÀÌ ³ª¿ÀÁö¸¸, À̿ܠ³úÀÇ ÀÌ»óÀ¸·Î ½Ã°¢ÀÇ Çü¼º°æ·Î¿¡ ÀÌ»óÀÌ À־ ¿ª½Ã ÀÌ»ó¼Ò°ßÀ» º¸ÀδÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • visual pathway
    ½Ã°¢°æ·Î
  • brain stem glioma
    ³úÁÙ±â½Å°æ¾Æ±³Á¾, ³ú°£±³Á¾
  • ependymal glioma
    ³ú½Ç¸·¼¼Æ÷Á¾, ³ú½Ç¸·±³Á¾
  • glioma
    ½Å°æ¾Æ±³Á¾, ±³Á¾
  • intracranial glioma
    ¸Ó¸®¼Ó½Å°æ¾Æ±³Á¾, µÎ°³³»±³Á¾
  • low grade glioma
    Àúµî±Þ±³Á¾
  • optic glioma
    ½Ã(°¢)½Å°æ±³Á¾
  • accessory pathway
    µ¡Àüµµ·Î, ºÎÀüµµ·Î
  • alternative complement pathway
    ´ëüº¸Ã¼°æ·Î
  • biosynthetic pathway
    »ýÇÕ¼º°æ·Î
  • classic complement pathway
    ÀüÇüÀûº¸Ã¼°æ·Î
  • coagulation pathway
    ÀÀ°í°æ·Î
  • extrinsic pathway of coagulation
    ¿ÜÀμºÀÀ°í°æ·Î
  • intrinsic pathway of coagulation
    ³»ÀμºÀÀ°í°æ·Î
  • interneuronal signaling pathway
    ½Å°æ¼¼Æ÷°£½ÅÈ£Àü´Þ°æ·Î
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • visual pathway
    ½Ã°¢°æ·Î
  • glioma
    ½Å°æ¾Æ±³Á¾
  • brain stem glioma
    ³úÁÙ±â½Å°æ¾Æ±³Á¾
  • pathway
    °æ·Î, Åë·Î
  • accessory pathway
    µ¡Àüµµ·Î, ºÎÀüµµ·Î
  • biosynthetic pathway
    »ýÇÕ¼º°æ·Î, »ýÇÕ¼º°úÁ¤
  • metabolic pathway
    ´ë»ç°æ·Î
  • sensory pathway
    °¨°¢·Î
  • binocular visual acuity
    ¾ç¾È½Ã·Â, µÎ´«½Ã·Â
  • visual acuity
    ½Ã·Â
  • visual cortex
    ½Ã°¢°ÑÁú, ½Ã°¢ÇÇÁú
  • visual disturbance
    ½Ã·ÂÀå¾Ö, ½Ã°¢Àå¾Ö
  • visual field defect
    ½Ã¾ß°á¼Õ
  • visual field
    ½Ã¾ß
  • visual hallucination
    ȯ½Ã
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • visual pathway
    ½Ã°¢°æ·Î
  • ependymal glioma
    (¢¡ependymoma) ³ú½Ç¸·¼¼Æ÷Á¾
  • glioma
    ½Å°æ¾Æ±³Á¾
  • intracranial glioma
    µÎ°³³»½Å°æ¾Æ±³Á¾, ¸Ó¸®¼Ó½Å°æ¾Æ±³Á¾
  • low grade glioma
    ¾ç¼º½Å°æ¾Æ±³Á¾
  • accessory pathway
    ºÎÀüµµ·Î
  • alternative complement pathway
    º¸Ã¼´ëü°æ·Î, µµ¿òü´ëü°æ·Î
  • biosynthetic pathway
    »ýÇÕ¼º°æ·Î, »ýÇÕ¼º°úÁ¤
  • classic complement pathway
    º¸Ã¼ÀüÇüÀû°æ·Î, µµ¿òüÀüÇüÀû°æ·Î
  • coagulation pathway
    ÀÀ°í°æ·Î
  • interneuronal signaling pathway
    ½Å°æ¼¼Æ÷°£½ÅÈ£Àü´Þ°æ·Î
  • internodal pathway
    ¸¶µð»çÀ̱æ
  • metabolic pathway
    ´ë»ç°æ·Î
  • motor pathway
    ¿îµ¿½Å°æ·Î
  • pathway
    °æ·Î, Åë·Î
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • VIU=>visual internal urethrotomy
    ³»½Ã°æÀû ³»¿äµµ Àý°³¼ú
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • hallucination, visual
    ȯ½Ã(ü³ãÊ)
  • red green visual substance
    Àû·Ï(»ö)½Ã°¢ ¹°Áú.
  • giant cell glioma
    °Å¼¼Æ÷±³Á¾.
  • glioma
    (½Å°æ)±³Á¾(ãêÌèÎïðþ).
  • glioma
    (½Å°æ)±³Á¾(ãêÌèÎïðþ)
  • glioma cysticum<³ª>
    ³¶¼º½Å°æ±³Á¾.
  • glioma multiforme<³ª>
    ´ÙÇü¼º ±³Á¾.
  • glioma of optic nerve
    ½Ã½Å°æ±³Á¾
  • glioma of optic nerve and chiasm
    ½Ã½Å°æ±³Â÷ ±³¼¼Æ÷Á¾.
  • glioma retinae<³ª>
    ¸Á¸·½Å°æ±³Á¾(ØÑدãêÌèÎïðþ).
  • Embden-Meyerhof pathway
    ¿¥µ§-¸¶À̾î·ÎÇÁ °æ·Î(ÌèÖØ)
  • Lemniscus pathway
    ¸ð´ë°æ·Î(Ù¶ÓáÌèÖØ)
  • accessory pathway
    ºÎÀüµµ·Î.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • visual pathway
    ½Ã·Î(ãÊÊÆÖØ).
  • visual pathway
    ½Ã(°¢)·Î(ãÊÊÆÖØ).
  • ependymal glioma
    »óÀDZ³Á¾(ß¾ëýÎïðþ).
  • giant cell glioma
    °Å¼¼Æ÷±³Á¾.
  • glioma
    (½Å°æ)±³Á¾(ãêÌèÎïðþ).
  • glioma
    (½Å°æ)±³Á¾(ãêÌèÎïðþ)
  • glioma cysticum<³ª>
    ³¶¼º½Å°æ±³Á¾.
  • glioma multiforme<³ª>
    ´ÙÇü¼º ±³Á¾.
  • glioma of optic nerve
    ½Ã½Å°æ±³Á¾
  • glioma of optic nerve and chiasm
    ½Ã½Å°æ±³Â÷ ±³¼¼Æ÷Á¾.
  • glioma retinae<³ª>
    ¸Á¸·½Å°æ±³Á¾(ØÑدãêÌèÎïðþ).
  • intracranial glioma
    µÎ°³³»±³Á¾(¡­Îïðþ).
  • nasal glioma
    ºñ½Å°æ±³Á¾
  • nasal glioma
    ºñ½Å°æ±³Á¾(Þ¬ãêÌèÎïðþ)
  • optic glioma
    ½Ã½Å°æ±³Á¾
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • VISUAL ORGAN
    ½Ã°¢±â°ü
    [¿¾ ¿ë¾î] ½Ã°¢±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • visual cycle
    ½Ã°¢ÁÖ±â(ãÊÊÆñÎÑ¢)
  • visual pigment
    ½Ã»ö¼Ò(ãÊßäáÈ)
  • visual purple
    ½ÃÀÚÈ«(ãÊí¹ûõ)
  • visual threshold
    "½Ã°¢(ãÊÊÆ) ¹®ÅÎ, ½Ã°¢ ¿ªÄ¡(ãÊÊÆæ¶ö·)"
  • alternative pathway
    ´ëü°æ·Î(ÓÛôðð¾ÌèÖØ)
  • aminoadipic pathway
    ¾Æ¹Ì³ë¾ÆµðÇÈ °æ·Î(ÌèÖØ)
  • amphibolic pathway
    ¾ç¸é¼º´ë»ç(ÕרüàõÓÛÞó)
  • arginine dihydrolase pathway
    ¾Æ¸£Áö´ÑµðÈ÷µå·Ñ·¹À̽º °æ·Î(ÌèÖØ)
  • biosynthetic pathway
    »ýÇÕ¼º°æ·Î(ßæùêà÷ÌèÖØ)
  • branched metabolic pathway
    ºÐÁö´ë»ç°æ·Î(ÝÂò«ÓÛÞóÌèÖØ)
  • central metabolic pathway
    ÁßÃß´ë»ç°æ·Î(ñéõÒÓÛÞóÌèÖØ)
  • C3 pathway
    C3 °æ·Î (ÌèÖØ)
  • C4 pathway
    C4 °æ·Î (ÌèÖØ)
  • cyclic metabolic pathway
    ȸ·Î ´ë»ç°æ·Î(üÞÖØÓÛÞóÌèÖØ)
  • DAP pathway
    "DAP °æ·Î(ÌèÖØ) (ÔÒ) diaminopimelate pathway,"
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glioma
    ±³Á¾
  • glioma multiforme
    ´ÙÇü¼º±³Á¾
  • optic pathway
    ½Ã½Å°æ·Î
  • pathway
    °æ·Î
  • visual
    ½Ã·ÂÀÇ, ½Ã°¢ÀÇ
  • visual acuity
    ½Ã·Â
  • visual center
    ½Ã°¢ÁßÃß
  • visual cortex
    ½Ã°¢ÇÇÁú
  • visual field defect
    ½Ã¾ß°á¼Õ
  • visual organ
    ½Ã°¢±â
  • visual window
    ½Ã¾ßâ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
VA vacuum aspiration; valproic acid; vasodilator agent; ventricular aneurysm; ventricular arrhythmia; v...
VAT variable antigen type; ventricular accommodation test; ventricular activation time; vesicular amine ...
EM Pathway Embden Meyerhof Pathway
AP accessory pathway; accounts payable; acid phosphatase; acinar parenchyma; action potential; active p...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NG 108-15 Neuroblastoma X Glioma hybrid cells
NG 108-15 Neuroblastoma x Glioma
LGG low grade glioma
NG 108-15 neuroblastoma X glioma hybrid
AP accessory pathway
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • central visual acuity
    Á᫐ ½Ã·Â
  • developmental test of visual motor integration
    ½Ã°¢ ¿îµ¿ ÅëÇÕ ¹ß´Þ °Ë»ç
  • visual aberration
    ½Ã°¢ Àå¾Ö
  • visual agnosia
    ½Ã°¢ ½ÇÀÎ
    ¸Á¸·¿¡¼­ Èĵο±ÀÇ Áö°¢Àüµµ·Î´Â Á¤»óÀε¥ º» °ÍÀ» ÀνÄÇÏÁö ¸øÇÏ´Â »óÅÂ.
  • visual angle
    ±¤°¢, ½Ã°¢
  • visual area
    ½Ã°¢ ¿µ¿ª
    ½Ã°¢ Åõ»ç ¿µ¿ª. Èĵο±ÀÇ ¼±Á¶ ÇÇÁú, ¼±Á¶ ÁÖÀ§ ÇÇÁú.
  • visual axis
    ½ÃÃà
    ¾È±¸ÀÇ ±¤Çа迡 À־ °áÁ¡°ú Á᫐ ¿Í¸¦ ÀÕ´Â ¼±.
  • visual center
    ½Ã°¢ ÁßÃß
    ÁßÁֽŰæ°è¿¡¼­ ½Ã°¢¿¡ Á÷Á¢ °ü¿©ÇÏ´Â ½Å°æ¼¼Æ÷ Áý´ÜÀ» °¡¸£Å°³ª ¸Á¸·À» Æ÷ÇÔ½ÃŰÁö ¾Ê´Â °ÍÀÌ º¸ÅëÀÌ´Ù.
  • visual cortex
    °¡½ÃÀû ÇÇÁú
  • visual experience
    °¡½ÃÀû °æÇè
  • visual field defect
    ½Ã¾ß °á¼Õ
    ¸Á¸·¿¡¼­ ´ë³ú ÇÇÁú¿¡ À̸£´Â ½Ã°¢°èÀÇ Àå¾Ö·Î ÀÎÇÑ ½Ã¾ßÀÇ ÀÌ»ó.
  • visual field test
    ½Ã¾ß °Ë»ç
    ÁÖº¯ ½Ã¾ß¿¡ ´ëÇÑ °Ë»ç.
  • visual image
    °¡½ÃÀû ¿µ»ó
  • visual memory test
    ½Ã°¢ ±â¾ï °Ë»ç
  • visual organ
    ½Ã°¢±â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
visual pathway Neural paths and connections within the central nervous system, beginning with the retina and terminating in the occipital cortex.
(05 Mar 2000)
brainstem glioma <oncology, tumour> This primary brain tumour occurs in the pons or the medulla. They account for approximately 15% of brain tumours in children.
Symptoms include double vision, facial weakness, vomiting and difficulty walking. Surgery is difficult due to location so radiation therapy and chemotherapy are used. Overall survival is 20 to 30%.
(27 Sep 1997)
gigantocellular glioma A histologic form of glioblastoma with large, often multinucleated, bizarre, tumour cells.
Synonym: giant cell monstrocellular sarcoma of Zulch.
(05 Mar 2000)
glioma <oncology, tumour> Neuroectodermal tumour of neuroglial origin: include astrocytoma, oligodendroglioma and ependymoma derived from astrocytes, oligodendrocytes and ependymal cells respectively. All infiltrate the adjacent brain tissue, but they do not metastasise.
(18 Nov 1997)
glioma of optic chiasm A slow-growing tumour, usually an astrocytoma, of the optic chiasm in children.
(05 Mar 2000)
glioma of the spinal cord A glial tumour of the spinal cord, commonly an ependymoma; neoplasms of the spinal cord are relatively rare, but glioma's constitute approximately one-fourth of the total.
(05 Mar 2000)
glioma, subependymal An ependymoma in which there is a diffuse proliferation of subependymal fibrillary astrocytes among the ependymal tumour cells. Discrete lobulated ependymal nodules in the walls of the anterior third or posterior fourth ventricle are commonly found at autopsy.
(12 Dec 1998)
mixed glioma <tumour> A glioma comprised of two or more malignant elements, most frequently astrocytoma and oligodendroglioma.
(05 Mar 2000)
nasal glioma <tumour> Term for a lesion that is probably not a true neoplasm, but an unusual anomaly consisting of glial tissue with reactive astrocytes, ganglionic neurons, and ependymal cells in small nodules at the base of the nose.
(05 Mar 2000)
optic glioma <oncology, tumour> A tumour of the optic nerve that can result in blindness to the pressure and destruction (caused by the tumour) of the optic nerve.
There is an association between optic gliomas and neurofibromatosis. Surgical excision or radiation therapy is the general coarse of treatment.
(27 Sep 1997)
optic nerve glioma <radiology> F = M, child / young adult (75% less than 10 yrs, 90% less than 20 yrs), fusiform, isodense mass, with or without enhancement, rarely calcified associated with neurofibromatosis Cf: optic nerve meningioma
(12 Dec 1998)
telangiectatic glioma <tumour> Glioma telangiectodes, a glioma in which the stroma has numerous, conspicuous, frequently dilated small blood vessels and capillaries, as well as large, endothelium-rimmed lakes of blood.
(05 Mar 2000)
alternative oxidase pathway Pathway of mitochondrial electron transport in higher plants, particularly in fruits and seeds, that does not involve cytochrome oxidase and thus is resistant to cyanide.
(18 Nov 1997)
alternative pathway See: complement activation.
(18 Nov 1997)
anabolic pathway <biochemistry> A reaction or series of reactions in a metabolic pathway that synthesise complex molecules from simpler ones, usually requiring the input of energy.
Compare: catabolic pathway.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glioma
    ½Å°æ±³Á¾
  • pathway
    Á¼Àº±æ;¿À¼Ö±æ
  • visual
    ½Ã°¢ÀÇ
  • key visual
    ÅÚ·¹ºñÀü ±¤°í¿¡¼­ °¡Àå Áß¿äÇÑ Æ÷ÀÎÆ®°¡ µÇ´Â ÇÑ È­¸é
  • visual
    ½Ã°¢ÀÇ;½Ã°¢¿¡ ÀνĵǴÂ;º¸±â À§ÇÑ;´«¿¡ º¸ÀÌ´Â
  • visual acuity
    ½Ã·Â
  • visual aids
    ½Ã°¢ ±³À°(¿ë ±â±¸)
  • visual flying
    À¯½Ã°è ºñÇà
  • visual purple
    ½ÃÈ«
  • visual show
    °ø°³ ¹æ¼Û
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á